ITeos Therapeutics is a biotechnology company that specializes in tumor immunology, cancer immunotherapy, and drug discovery. Founded by Michel Detheux in 2011, ITeos Therapeutics is backed by investors that include 6 Dimensions Capital, Boxer Capital, curative ventures, Fund+, HBM Partners, Invus, Janus Henderson Investors, MPM Capital, RA Capital Management, RTW Investments LLC, S.R.I.W., SFPI-FPIM, and Vives Fund and is headquartered in Gosselies.
FOUNDED:
2011
INDUSTRY:
Biotechnology, Health Care, Medical
FOUNDERS:
Michel Detheux
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
